Cargando…

Maximum inspiratory pressure as a clinically meaningful trial endpoint for neuromuscular diseases: a comprehensive review of the literature

Respiratory muscle strength is a proven predictor of long-term outcome of neuromuscular disease (NMD), including amyotrophic lateral sclerosis, Duchenne muscular dystrophy, and spinal muscular atrophy. Maximal inspiratory pressure (MIP), a sensitive measure of respiratory muscle strength, one of sev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schoser, Benedikt, Fong, Edward, Geberhiwot, Tarekegn, Hughes, Derralynn, Kissel, John T., Madathil, Shyam C., Orlikowski, David, Polkey, Michael I., Roberts, Mark, Tiddens, Harm A. W. M., Young, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5353799/ https://www.ncbi.nlm.nih.gov/pubmed/28302142 http://dx.doi.org/10.1186/s13023-017-0598-0

Ejemplares similares

A Novel Rapid MALDI-TOF-MS-Based Method for Measuring Urinary Globotriaosylceramide in Fabry Patients
por: Alharbi, Fahad J., et al.
Publicado: (2016)

Acute Confusion as an Initial Presentation of SARS-CoV-2 Infection
por: Butt, Isabel, et al.
Publicado: (2021)

Maximum static inspiratory and expiratory pressures with different lung volumes
por: Lausted, Christopher G, et al.
Publicado: (2006)

Clinical Trial Endpoints and Their Clinical Meaningfulness in Early Stages of Alzheimer’s Disease
por: Cohen, S., et al.
Publicado: (2022)

Lung function and breathing patterns in hospitalised COVID-19 survivors: a review of post-COVID-19 Clinics
por: Stockley, James A., et al.
Publicado: (2021)

Evaluation of myotonometry for myotonia, muscle stiffness and elasticity in neuromuscular disorders
por: Lukas, Katharina, et al.
Publicado: (2023)

Time to Next Treatment as a Meaningful Endpoint for Trials of Primary Cutaneous Lymphoma
por: Campbell, Belinda A., et al.
Publicado: (2020)

REWIND Diabetes for Octogenarians
por: Geberhiwot, Tarekegn
Publicado: (2021)

Introducing fuzziness into maximum common substructures for meaningful cluster characterisation
por: Herhaus, Christian
Publicado: (2014)

Patient-Centered Identification of Meaningful Regulatory Endpoints for Medical Devices to Treat Parkinson’s Disease
por: Benz, Heather L., et al.
Publicado: (2021)

Maximum inspiratory pressure, a surrogate parameter for the assessment of ICU-acquired weakness
por: Tzanis, Georgios, et al.
Publicado: (2011)

Efficacy of Incentive Spirometer in Increasing Maximum Inspiratory Volume in an Out-Patient Setting
por: Toor, Harjyot, et al.
Publicado: (2021)

Frequency and satisfaction of conventional and complementary or alternative therapies for neuromuscular disorders
por: Böhne, Lene Änne, et al.
Publicado: (2023)

Medium-Term Outcomes in Severely to Critically Ill Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection
por: Gautam, Nandan, et al.
Publicado: (2021)

Cervical spinal cord injury: tailoring clinical trial endpoints to reflect meaningful functional improvements
por: Bond, Lisa M., et al.
Publicado: (2014)

CRISPR-cas gene-editing as plausible treatment of neuromuscular and nucleotide-repeat-expansion diseases: A systematic review
por: Babačić, Haris, et al.
Publicado: (2019)

Maximum inspiratory pressure and rapid shallow breathing index as predictors of successful ventilator weaning
por: Bien, Umilson dos Santos, et al.
Publicado: (2015)

Effects of diaphragmatic control on the assessment of sniff nasal inspiratory pressure and maximum relaxation rate
por: Benício, Kadja, et al.
Publicado: (2015)

Effect of Dialysis on Maximum Inspiratory and Expiratory Pressures in End Stage Renal Disease Patients
por: Tavana, Sasan, et al.
Publicado: (2015)

Impact of long-term elosulfase alfa treatment on clinical and patient-reported outcomes in patients with mucopolysaccharidosis type IVA: results from a Managed Access Agreement in England
por: Cleary, Maureen, et al.
Publicado: (2021)

Systematic review of the incidence and clinical risk predictors of atrial fibrillation and permanent pacemaker implantation for bradycardia in Fabry disease
por: Vijapurapu, Ravi, et al.
Publicado: (2023)

Intra- and inter-rater reliability of maximum inspiratory pressure measured using a portable capsule-sensing pressure gauge device in healthy adults
por: Jalan, Nikita S, et al.
Publicado: (2015)

A study on the safety and efficacy of reveglucosidase alfa in patients with late-onset Pompe disease
por: Byrne, Barry J., et al.
Publicado: (2017)

Inspiratory muscle training in children and adolescents living with neuromuscular diseases: A pre-experimental study
por: Human, Anri, et al.
Publicado: (2021)

Cardiac device implantation and device usage in Fabry and hypertrophic cardiomyopathy
por: Vijapurapu, Ravi, et al.
Publicado: (2022)

Prolonged confusional state as first manifestation of COVID‐19
por: Butt, Isabel, et al.
Publicado: (2020)

Prediction for the maximum inspiratory pressure value from the thoracic expansion measurement in Indonesian healthy young adults
por: Moeliono, Marina, et al.
Publicado: (2022)

The metabolic cost of inspiratory muscle training in mechanically ventilated patients in critical care
por: Jenkins, Timothy O., et al.
Publicado: (2023)

A comparative study of inspiratory muscle strength, neuromuscular drive to breath and its ratio in weaning outcome
por: Nemer, SN, et al.
Publicado: (2005)

Meaningful change: Defining the interpretability of changes in endpoints derived from interactive and mHealth technologies in healthcare and clinical research
por: Byrom, B, et al.
Publicado: (2020)

Late-onset neuromuscular disorders in the differential diagnosis of sarcopenia
por: Hofmeister, Fabian, et al.
Publicado: (2021)

Safety and efficacy of pegunigalsidase alfa in patients with Fabry disease who were previously treated with agalsidase alfa: results from BRIDGE, a phase 3 open-label study
por: Linhart, Aleš, et al.
Publicado: (2023)

Optimal method for assessment of respiratory muscle strength in neuromuscular disorders using sniff nasal inspiratory pressure (SNIP)
por: Kaminska, Marta, et al.
Publicado: (2017)

Influence of Dynamic Neuromuscular Stabilization Approach on Maximum Kayak Paddling Force
por: Davidek, Pavel, et al.
Publicado: (2018)

Using qualitative interviews to identify patient-reported clinical trial endpoints and analyses that are the most meaningful to patients with advanced breast cancer
por: Flood, Emuella, et al.
Publicado: (2023)

Inspiratory Myoclonus
por: Dekker, Marieke C. J., et al.
Publicado: (2019)

Myocardial Storage, Inflammation, and Cardiac Phenotype in Fabry Disease After One Year of Enzyme Replacement Therapy
por: Nordin, Sabrina, et al.
Publicado: (2019)

Exploratory composite endpoint demonstrates benefit of trilaciclib across multiple clinically meaningful components of myeloprotection in patients with small cell lung cancer
por: Dómine Gómez, Manuel, et al.
Publicado: (2021)

A randomised controlled trial evaluating arrhythmia burden, risk of sudden cardiac death and stroke in patients with Fabry disease: the role of implantable loop recorders (RaILRoAD) compared with current standard practice
por: Vijapurapu, Ravi, et al.
Publicado: (2019)

Study of indications for cardiac device implantation and utilisation in Fabry cardiomyopathy
por: Vijapurapu, Ravi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_0vit40r0ubc61uqvjndc9kumqt